Clicks Group (CLS) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
8 Jul, 2026Executive summary
Group delivered resilient results amid tough trading conditions, with intensified competition and constrained consumer spending, especially among middle-income households.
Achieved milestone of over 1,000 stores and nearly 800 pharmacies, with ClubCard membership growing by 800,000 to 12.9 million active members, contributing 83.7% of retail turnover.
UPD showed strong growth in wholesale and preferred bulk contracts, with disciplined expense management and sustainability initiatives such as expanding the electric vehicle fleet.
R2.3 billion was returned to shareholders via dividends and share buybacks, including R752 million in share repurchases.
Delays in warehouse management system implementation reduced retail turnover by R175 million, but product availability normalized by period end.
Financial highlights
Group turnover increased by 7.4% year-over-year to R24.9 billion; retail turnover up 5.4%, UPD/distribution turnover up 13%.
Trading profit rose 7.4% to R2.3 billion; diluted headline EPS up 8.1% to 652.8 cents.
Interim dividend increased by 8.4% to 258 cents per share.
Cash generated from operations after working capital was R1.9 billion; return on equity at 45.7%.
Gross profit increased 4.7% to R5.8 billion; total income up 6.5% to R7.6 billion.
Outlook and guidance
Guidance for full-year diluted headline EPS growth of 4% to 9%, reflecting uncertainty from geopolitical events, inflation, and consumer spend.
Targeting 40–50 new stores and pharmacies in the year, with 10 concept stores to be piloted and expansion of UniCare format.
Continued investment in IT, store expansion, and differentiated concept stores; focus on cost management and margin improvement.
Latest events from Clicks Group
- Turnover rose 7.4% to R19.5bn, led by pharmacy and distribution growth; retail faced some headwinds.CLS
Trading update - EPS up 14.1%, ROE at 49.2%, with strong cash flow and market share gains.CLS
H2 2025 - EPS up 14.3%, turnover up 9.2%, and 2025 targets 40–50 new stores and pharmacies.CLS
H2 2024 - Strategic focus on store growth, omnichannel, and efficiency drives robust expansion and margins.CLS
Deutsche Bank ADR Virtual Investor Conference - HEPS up 13.2%, turnover up 6.2%, and 45–55 new stores planned amid strong cash flow.CLS
H1 2025